Abstract
Parsonage-Turner syndrome (PTS) is an idiopathic condition that may be triggered by vaccination against SARS-CoV-2. High-resolution ultrasound can support the diagnosis and monitoring of PTS patients by demonstrating specific nerve abnormalities. The recently implemented superb microvascular imaging technology can help stratify the prognosis of these patients, with the potential to contribute to the clinical management of PTS.